logo
How Trump Threw Out the Pandemic Playbook

How Trump Threw Out the Pandemic Playbook

The Atlantic20 hours ago
As of last month, there is no one left in the White House whose sole job is to keep the nation safe from biological threats. The leader of the National Security Council's biosecurity directorate recently resigned. His staff had been pushed out, and his unit is now defunct. The Office of Pandemic Preparedness and Response Policy, established by Congress in 2022, has dwindled from a staff of about 20 under President Joe Biden to a staff of zero.
The Trump administration has said that it's just reorganizing the bureaucracy and is prepared to handle biothreats. But our experience suggests otherwise. Without a leader from the NSC embedded in the White House and ready to coordinate other agencies, more people—including Americans—will get sick and die.
We have spent years helping lead the U.S. government's efforts to contain the deadliest biological threats. One of us, Beth Cameron, helped found the NSC's biosecurity office, in 2016—created as a response to a deadly Ebola outbreak in West Africa that had begun a couple of years earlier. Ebola is a gruesome, highly contagious disease that causes its victims' organs, blood vessels, and immune cells to fail. The average lethality rate is about 50 percent. That outbreak killed more than 11,000 people across West Africa and cost the U.S. government billions of dollars to help contain. Despite our government's best efforts, 11 cases ultimately reached the U.S., and two were fatal.
President Donald Trump terminated the NSC's biosecurity office during his first term, but Biden reestablished it—and just in time. In early February 2021, an ominous email came to the White House from federal health officials: reports of Ebola outbreaks in Guinea and the Democratic Republic of the Congo. The cases were close to the borders of Uganda and Rwanda, major travel hubs for the region.
The White House was already managing the coronavirus pandemic and resulting economic crisis. But leaving Guinea and Congo to handle the Ebola outbreaks on their own was risky. So we activated a system developed through hard-learned lessons from past deadly outbreaks, designed to help contain them at their sources and to prepare for the worst at home.
We sent public-health professionals to advise the affected countries. We took inventory of vaccines and other supplies so we would be ready to deploy them. We relied on a painstaking system of testing, vaccinations, and predeparture screenings in Congo and Guinea. We ensured that anyone who had been to an affected country and was seeking to come to the U.S. was funneled to one of a handful of American airports. The CDC and the Department of Homeland Security activated a program for tracing and contacting passengers after their arrival. One of us, Jon Finer—the principal deputy national security adviser at the time—led a team of senior health and national-security officials from across the government; it met every day to coordinate all of the moving parts, and to keep the president and other senior officials informed.
It worked. The disease was entirely contained within the two source countries—no cases reached the U.S.—and 18 people died, a number that could have been exponentially higher.
To strengthen our responses to future pandemics, lawmakers soon established the position of a U.S. coordinator for global health security; one of us, Stephanie Psaki, was the first person to hold that job. They also created the Office of Pandemic Preparedness and Response Policy in the White House. The Trump administration, tasked with upholding the law, is supposed to be staffing these offices. Not only has it failed to do that, but in just six months, it also has dismantled many of the early-warning-and-response systems that were built over decades.
In Trump's second term, his team has fired thousands of public-health experts at the CDC, the FDA, and other agencies. It has canceled investments in safeguards against pandemic influenza, undermined confidence in vaccines, and cut funding for potential future outbreaks. It killed USAID and is scaling down the CDC's global role, canceling many of the programs that maintained ties to countries where disease outbreaks occur. It has withdrawn the U.S. from the World Health Organization. And it has created confusion about who in the U.S. government is in charge of the system for tracking deadly biothreats, whether naturally occurring, accidental, or deliberate.
Put another way: The second Trump administration inherited a playbook, and then pushed out the people who knew how to run the plays.
The United States is dealing with many biological threats at home and abroad, such as the bird flu and measles—with the latter, America is already facing the worst outbreak in decades. Scientists estimate about a 50–50 chance of another pandemic as severe as the coronavirus occurring in the next 25 years. The probability is even higher for smaller-scale threats, such as periodic Ebola outbreaks. Deadly biothreats are more and more likely to emerge for a range of reasons, including increased interaction between humans and animals, labs without sufficient biosecurity systems, easier public access to the information and technology needed to create or manipulate a bioagent, and continued concerns about the development of biological weapons by nefarious actors. The risk of death and economic disruption is only growing.
America rebuilt the system of disease detection and response after the first Trump administration damaged it. That will be harder to do this time around. Far more officials have left the government. Will they be willing to come back, given the degree to which their work has been disparaged and their job security eviscerated?
Stopping deadly diseases from reaching the United States is challenging at the best of times. Absent trusting relationships and, truth be told, a fair amount of pressure, affected countries aren't always forthcoming with information. (We dealt with one case that required resorting to threats to withhold U.S. support if the other government didn't share more data about an emerging outbreak.) Health imperatives can collide with political ones, such as when a country has to consider restricting travel. Questions can arise about how much of a vaccine or treatment should be shared with other countries, and how much should be kept at home (if a vaccine or treatment exists at all).
But these are all reasonable policy debates that assume the system is basically functioning. In a worst-case scenario, we might not even know about a disease until it has started spreading in a major city with an international airport. With no warning, we will have less ability to stop the disease at its source, and less power, if it reaches our shores, to save American lives. The odds of us facing that scenario have now gone way up. This would be a terrible tragedy, and all the more so because it would be self-inflicted.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's EU Allies Send Him New Ukraine Plea Ahead of Putin Summit
Trump's EU Allies Send Him New Ukraine Plea Ahead of Putin Summit

Newsweek

time2 minutes ago

  • Newsweek

Trump's EU Allies Send Him New Ukraine Plea Ahead of Putin Summit

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. European Union (EU) leaders issued a fresh joint appeal to U.S. President Donald Trump on Ukraine, imploring him ahead of his crunch summit with Russian President Vladimir Putin in Alaska on Friday, August 15. Kyiv and its European allies fear Trump will consent to the concession of Ukrainian territory Moscow has seized during its invasion, which they say will reward Russia for its unlawful aggression and signal that it could take similar action elsewhere. Twenty-six EU leaders—Hungary being the only member state that did not want to co-sign—said in the statement Tuesday that they welcomed Trump's efforts to end Russia's invasion and seek "a just and lasting peace and security for Ukraine". But they warned: "A just and lasting peace that brings stability and security must respect international law, including the principles of independence, sovereignty, territorial integrity and that international borders must not be changed by force. "The people of Ukraine must have the freedom to decide their future. The path to peace in Ukraine cannot be decided without Ukraine. Meaningful negotiations can only take place in the context of a ceasefire or reduction of hostilities. "Russia's war of aggression against Ukraine has wider implications for European and international security. We share the conviction that a diplomatic solution must protect Ukraine's and Europe's vital security interests." This is a developing article. Updates to follow.

South Korea's Lee, Trump to hold summit at White House on Aug. 25
South Korea's Lee, Trump to hold summit at White House on Aug. 25

UPI

time2 minutes ago

  • UPI

South Korea's Lee, Trump to hold summit at White House on Aug. 25

1 of 2 | South Korean President Lee Jae Myung will travel to Washington this month for a summit with U.S. President Donald Trump on Aug. 5, Lee's office said Tuesday. File Photo by Thomas Maresca/UPI | License Photo SEOUL, Aug. 12 (UPI) -- South Korean President Lee Jae Myung will travel to Washington to hold a summit with U.S. President Donald Trump on Aug. 25, Lee's office said Tuesday, with trade and defense issues expected to be at the top of the agenda. The three-day visit will be Lee's first trip to the United States since taking office in June, presidential spokeswoman Kang Yu-jung said at a press briefing. "The two leaders plan to discuss ways to develop the Korea-U.S. alliance into a future comprehensive strategic alliance in response to the changing international security and economic environment," Kang said. "They will also discuss ways to further strengthen the robust South Korea-U.S. combined defense posture and to cooperate to establish peace and achieve denuclearization on the Korean Peninsula," she added. The summit comes weeks after Seoul and Washington struck a trade deal that lowered Trump's threatened 25% tariffs on South Korean goods to 15%. As part of the package, South Korea pledged to invest $350 billion in the United States and to purchase $100 billion in U.S. energy. Based on the tariff deal, Trump and Lee will consult on economic cooperation in semiconductors, batteries and shipbuilding, as well as partnerships in advanced technologies and key minerals, Kang said. The future of the decades-old South Korea-U.S. military alliance is also expected to be in the spotlight as the two countries prepare to kick off their annual Ulchi Freedom Shield joint exercise on Monday. During his previous term in office, Trump called for massive increases in Seoul's financial contribution for the 28,500 U.S. forces stationed in Korea. Seoul signed a new five-year cost-sharing agreement with Washington in October, but Trump has suggested he would look to renegotiate the terms of the deal amid calls for allies to increase their defense spending. "South Korea is making a lot of money, and they're very good," Trump told reporters at a Cabinet meeting in the White House last month. "They're very good, but, you know, they should be paying for their own military." On Friday, Gen. Xavier Brunson, commander of U.S. Forces Korea, discussed the need to restructure the military alliance in response to an evolving regional security environment. "Alliance modernization ... reflects the recognition that the world's changed around us," Brunson told local reporters at a press briefing in Pyeongtaek. "We have a nuclear-armed adversary who's north of the border. We have increasing involvement of Russia, along with the DPRK, and we also have the Chinese and the threat that they pose to a free and open Indo-Pacific." The Democratic People's Republic of Korea is the official name of North Korea. Brunson avoided the question of a potential of U.S. troop reduction on the peninsula, stressing military capabilities and strategic flexibility over numbers ahead of the Lee-Trump summit. "We're going to have two chief executives sitting down together to discuss not only the security situation in the region, but the security situation in the world," he said. "For us, it's about the capabilities. We want to have the right capabilities resident on the Peninsula." Lee will be in the United States from Aug. 24-26 for his summit with Trump. In response to local media reports that Lee may also stop in Japan around the time of his U.S. trip, presidential spokeswoman Kang said that nothing had been confirmed.

Trump May Allow Nvidia (NVDA) to Sell Scaled-Down Blackwell Chips to China
Trump May Allow Nvidia (NVDA) to Sell Scaled-Down Blackwell Chips to China

Business Insider

time9 minutes ago

  • Business Insider

Trump May Allow Nvidia (NVDA) to Sell Scaled-Down Blackwell Chips to China

President Donald Trump said on Monday that he might allow Nvidia (NVDA) to sell a scaled-down version of its most advanced AI chip, the Blackwell, to China. Indeed, he told reporters that he would consider approving the sale if the chip's performance was reduced by about 30% to 50%, describing it as a 'somewhat enhanced — in a negative way — Blackwell' processor. Trump's comments came as he confirmed a separate deal that allows Nvidia to sell its less-powerful H20 AI chip to China if the company pays 15% of the revenue from those sales to the U.S. government. Advanced Micro Devices (AMD) will also pay the same percentage on revenue from its MI308 chip. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The H20 revenue-sharing deal and the possibility of a similar arrangement for the Blackwell are examples of Trump's strategy to secure financial benefits for the U.S. in exchange for lower trade restrictions. However, experts warn that these kinds of agreements could set a precedent for all American companies selling to China and might weaken the national security argument behind the current export controls. Indeed, it is worth noting that U.S. restrictions currently classify the Blackwell chip as too powerful to be sold in China. As a result, Nvidia and AMD have both seen their China sales drop sharply due to these rules. And while the Trump administration has started issuing permits for some shipments, the approved chips are older models that are no more advanced than those already made in China, thereby limiting their appeal. However, a newer but less powerful Blackwell could help Nvidia win back customers in China if approved. Unsurprisingly, though, Nvidia has said it is working on a new chip for the Chinese market and will look to receive export approval. What Is a Good Price for NVDA? Turning to Wall Street, analysts have a Strong Buy consensus rating on NVDA stock based on 35 Buys, three Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average NVDA price target of $187.57 per share implies 3% upside potential.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store